Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2016 10:57 ET | Source: Checkpoint Therapeutics, Inc

Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor

JERUSALEM and NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech...
December 21, 2015 08:00 ET | Source: Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Closes $58M in Private Placement Financing

NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ:FBIO) Company, announced today that it has closed on a total of $58 million,...
October 16, 2015 07:30 ET | Source: Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Announces Appointment of James F. Oliviero, III, as President & Chief Executive Officer

NEW YORK, Oct. 16, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint"), a Fortress Biotech Company (NASDAQ:FBIO), today announced that Mr. James F. Oliviero, III, has been appointed...
September 08, 2015 16:05 ET | Source: Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Files to Become a Public Reporting Company

NEW YORK, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint"), a Fortress Biotech Company, (NASDAQ:FBIO) announced that it filed a registration statement on Form 10 with the...